AI assistant
Apellis Pharmaceuticals, Inc. — Director's Dealing 2020
Apr 27, 2020
31417_dirs_2020-04-27_05a3dc3e-56d1-4c90-a971-e10a23ad5bb7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Apellis Pharmaceuticals, Inc. (APLS)
CIK: 0001492422
Period of Report: 2020-04-02
Reporting Person: Brown Victoria L. (Program Team Lead)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3125 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $18.98 | 2029-03-06 | Common Stock (70000) | Direct | |
| Stock Option (Right to Buy) | $44.33 | 2030-02-09 | Common Stock (12075) | Direct | |
| Stock Option (Right to Buy) | $28.37 | 2030-03-24 | Common Stock (6675) | Direct |
Footnotes
F1: Consist of shares of Common Stock issuable under 2,013 restricted stock units ("RSUs") granted on February 10, 2020 and 1,112 RSUs granted on March 25, 2020. Each RSU was granted pursuant to the Company's 2017 Stock Incentive Plan and represents the right to receive one share of Common Stock upon vesting. The RSUs will vest as to 25% of the shares underlying the RSUs on the first anniversary of the date of grant, and 25% of the shares underlying the RSUs on each anniversary of grant date thereafter through the fourth anniversary of the grant.
F2: This option was granted on March 7, 2019 and will vest as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to continued service.
F3: This option was granted on February 10, 2020 and will vest as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to continued service.
F4: This option was granted on March 25, 2020 and will vest as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to continued service.